J. Michel

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

Marianne Paesmans, Jean‐Paul Sculier, P Libert et al. · Journal of Clinical Oncology · 1995 · 393 citations

A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.

Jean Klášterský, Jean‐Paul Sculier, P Ravez et al. · Journal of Clinical Oncology · 1986 · 136 citations

Standard-dose Arm, Medicine, Metronomic Therapy +12

Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party

Marianne Paesmans, Jean‐Paul Sculier, P Libert et al. · European Journal of Cancer · 1997 · 83 citations

Medicine, Cancer Management, Pathology +8

Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.

Jean‐Paul Sculier, Marianne Paesmans, G. Bureau et al. · Journal of Clinical Oncology · 1993 · 78 citations

Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.

Jean‐Paul Sculier, M Paesmans, G. Bureau et al. · Journal of Clinical Oncology · 1996 · 72 citations